6 research outputs found

    IL-17 expression in the submucosa of bronchial biopsies of 4 groups of studied population.

    No full text
    <p>atopic inhaled corticosteroid (ICS) user (frame A), nonatopic ICS user (frame B), atopic non-ICS user (frame C), nonatopic non-ICS user (frame D). Single staining for IL-17 (frame E; blue) and MPO (frame F; red) and double staining for IL-17 and MPO (frame G; purple) in adjacent sections of a nonatopic non-ICS user asthmatic patient. Single staining for IL-17 (frame H; blue) and EPX (frame I; red) and double staining for IL-17 and EPX (frame J; purple) in adjacent sections of an atopic non-ICS user asthmatic patient.</p

    Positive correlation between the number of IL-17<sup>+</sup> cells and neutrophils in the submucosa of bronchial biopsies from atopic (r<sub>s</sub> = 0.44; p<0.001) and nonatopic (r<sub>s</sub> = 0.45, p = 0.009) asthmatics (A), or from asthmatics who are inhaled corticosteroid (ICS) (r<sub>s</sub> = 0.35; p = 0.01) and non-ICS (r<sub>s</sub> = 0.48; p<0.0001) users (B).

    No full text
    <p>Positive correlation between the number of IL-17<sup>+</sup> cells and neutrophils in the submucosa of bronchial biopsies from atopic (r<sub>s</sub> = 0.44; p<0.001) and nonatopic (r<sub>s</sub> = 0.45, p = 0.009) asthmatics (A), or from asthmatics who are inhaled corticosteroid (ICS) (r<sub>s</sub> = 0.35; p = 0.01) and non-ICS (r<sub>s</sub> = 0.48; p<0.0001) users (B).</p
    corecore